EHS
EHS

New patent for Provepharm Sas drug BLUDIGO – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent for Provepharm Sas drug BLUDIGO


Annual Drug Patent Expirations for BLUDIGO

Bludigo is a drug marketed by Provepharm Sas and is included in one NDA. There is one patent protecting this drug.

This drug has two patent family members in two countries.

The generic ingredient in BLUDIGO is indigotindisulfonate sodium. Additional details are available on the indigotindisulfonate sodium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Provepharm Sas drug BLUDIGO



Source link

EHS
Back to top button